Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825715 | Clinical Therapeutics | 2013 | 14 Pages |
Abstract
In this study of CAD Korean patients who have undergone PCI, the antiplatelet efficacy of clopidogrel napadisilate was noninferior to that of clopidogrel bisulfate after 4 weeks of maintenance treatment. No statistically significant difference was found in tolerability between the 2 treatment groups. ClinicalTrials.gov identifier: NCT01584791.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Jun-Bean MD, Bon-Kwon MD, PhD, Woong-Gil MD, Seok-Yeon MD, Jinsik MD, PhD, Jun MD, PhD, Chang Gyu MD, PhD, Hyo-Soo MD, PhD,